Enesi Pharma’s ImplaVax Technology Platform Spotlighted in Medical Device Developments Article on Elimination of Cold Chain Logistics

Enesi Pharma is pleased to acknowledge Lynette Eyb’s excellent article ‘A Total Meltdown’ in Medical Device Developments’  where the potential of Enesi’s proprietary ImplaVax^® formulation and delivery technologies are discussed.

The Article ‘A Total Meltdown‘ highlights how next generation vaccination technologies such as ImplaVax^® needle-free, thermally stable unit solid dose vaccination platform could make a material impact on the ease of future deployment and reduce or eliminate the burden of cold chain logistics.